UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000013502 |
|---|---|
| Receipt number | R000015609 |
| Scientific Title | Phase II study of erlotinib as first line chemotherapy in patients with lung adenocarcinoma with brain metastasis and EGFR mutations. |
| Date of disclosure of the study information | 2014/03/25 |
| Last modified on | 2018/09/26 09:20:13 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/03/24 22:35:41 | ||
| 2 | Update | 2016/05/23 21:08:34 | Email Name of primary person or sponsor Organization |
|
| 3 | Update | 2018/09/26 09:20:13 | Recruitment status |
